Excited to see our CSO‘s newest paper about what happens to therapeutic antibodies once they are in the brain.
CSO, InCephalo & Groupleader, Institute of Laboratory Animal Science, University of Zurich
I am delighted to see our review on exit pathways of therapeutic antibodies from the brain and potential strategies to retain them there published in iScience. Congratulations Linda Schellhammer, PhD, Michal Beffinger, Ulisse Salazar, Jon Laman and Thorsten Buch! Did you ever wonder what happens to a therapeutic antibody once it is deployed behind the blood-brain barrier into the central nervous system compartment? Reaching the brain may not be the end of the journey. You may also want to check out InCephalo’s vision of Compartment-Locked Therapeutics. https://lnkd.in/edPynaGK
